GenVivo, Inc. Email Format

Biotechnology ResearchCalifornia, United States11-50 Employees

GenVivo, Inc. is a clinical-stage biotechnology company based in San Marino, California. It develops off-the-shelf therapeutic approaches designed to stimulate the patient’s immune system to recognize and attack cancer. These therapies are intended to be accessible and to reduce the time and cost typically associated with personalized cancer vaccines.
In April 2025, GenVivo presented preclinical data on GEN-1013, an interleukin-12 immunotherapy, at the American Association for Cancer Research annual meeting. Leveraging a patented, off-the-shelf vector platform, the company aims to activate immune responses against a broad range of a patient’s tumor antigens, positioning itself within the biotechnology research space focused on cancer treatment.

Sign up for free to view info

Company overview Employee directory